R
  • 773.714.0705
  • Home
  • About Us
  • Specialty
  • Activities
    • Live
    • Online
  • Outcomes & Toolkits
New User? Login
Certificate Use Certificate Code

Overview

Establishing Effective Interprofessional Care Pathways for Obstructive Sleep Apnea

Personalized Learning Platform powered by ACHL CustomED®

SHARE WITH COLLEAGUE

Activity URL:

https://www.achlcme.org/detail/5068/Establishing-Effective-Interprofessional-Care-Pathways-...

Click the "Start Activity" button to indicate you have reviewed the CME/CE information for this activity.

Start Activity

CME/CE is no longer available for this activity

Establishing Effective Interprofessional Care Pathways for Obstructive Sleep Apnea
Format
Personalized Education (powered by ACHL CustomED®)
Time to Complete
Up to 3.00 hr(s).
Release Date
April 15, 2024
Expires On
April 15, 2025

Despite obstructive sleep apnea (OSA) being a source of significant morbidity and mortality, it is underdiagnosed and undertreated. Poor patient outcomes stem from inadequate and/or inconsistent screening in high-risk patients, a dearth of sleep specialists to effectively manage all patients, and poor collaboration amongst disciplines to evaluate and manage patients. And while CPAP remains the standard of care for patients with OSA, it is insufficient for a sizeable number of patients and not tolerated by patients with high-risk comorbidities. 

Are you equipped to:
• Recognize typical and atypical presentations of OSA?
• Conduct effective screenings for your patients at high risk?
• Select and interpret the best sleep test for a patient?
• Provide a timely referral for a formative diagnosis to ensure optimal management?
• Coordinate and manage care for your patients with OSA?

Developed by experts specializing in sleep management, this dynamic online slide library allows you to choose topics that are most relevant to your clinical setting and customize an educational activity to improve the quality of care you provide to your patients with OSA. It's time to help your patients get the quality sleep they deserve and reduce the potential for complications! 

This activity is intended for multidisciplinary healthcare providers involved in the care of patients with obesity who may also have OSA, including primary care providers pharmacists, dentists, surgeons, endocrinologists, cardiologists, pulmonologists, neurologists, obesity care specialists, and advance practice providers.

Obstructive sleep apnea (OSA) is a chronic disorder characterized by repetitive collapse of the upper airway during sleep. In the United States, OSA is common due to the high prevalence of risk factors, such as obesity and advanced age. The impacts of OSA cause major morbidity and may be life-threatening. Sleep disruptions caused by OSA can lead to impaired vigilance, daytime somnolence, performance deficits, morning headaches, mood disturbances, cognitive dysfunction, impaired workplace productivity, and motor vehicle accidents. OSA is a source of major morbidity and mortality, and providers must be knowledgeable and competent to identify those at risk and provide a timely diagnosis to ensure that patients receive optimal management.

Upon completion of this activity, learners will be able to:

• Implement routine OSA screening for patients with obesity and other OSA risk factors.
• Identify tools that can aid in screening patients for OSA.
• Initiate diagnostic workups for patients with suspected OSA.
• Evaluate results from OSA diagnostic studies.
• Implement multidisciplinary approaches to provide comprehensive management of OSA.

This educational activity is presented in collaboration with Rush University Medical Center and the Academy for Continued Healthcare Learning (ACHL).      

This activity is supported by an educational grant from Lilly.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker

Content is displayed in these sections:

OSA Burden of Disease/Epidemiology 
Screening At-Risk Patients for OSA
Confirming a Diagnosis of OSA
Management Approaches 
Care Coordination 
Role of Pharmacists
Targeted Pathway: Specialists 
Targeted Pathway: Dentists 

On December 20, 2024, tirzepatide received FDA approval for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity.

Atul Malhotra, MD (Chair)
Kenneth Moser Professor of Medicine
Chief, Division of Pulmonary and Critical Care
University of California
San Diego, CA

Neomi Shah, MD, MPH, MS (Chair)
Associate Dean for Faculty Career Advancement
The Office of Faculty Development
System Vice Chair of Medicine for Faculty Affairs
The Samuel Bronfman Department of Medicine
Professor of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine
Icahn School of Medicine at Mount Sinai
New York, NY  

Fernanda Almeida, DDS, PhD (Co-chair)
Professor, Faculty of Dentistry
University of British Columbia
Vancouver, Canada 

Shana Castillo, PharmD, MBA, RPh (Co-chair)
Associate Professor, Pharmacy Practice
School of Pharmacy and Health Professions
Creighton University
Omaha, NE

It is the policy of Rush University Medical Center and the Office of Interprofessional Continuing Education (ICPE) to ensure that its CE activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CE.  All individuals in control of educational content must disclose all financial relationships with ineligible companies in the past 24 months.  An ineligible company is an entity whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. All conflicts of interest, including potential ones, for individuals in control of educational content are mitigated prior to the planning, implementation, or evaluation of the continuing education activity.

The IPCE identifies the presence or absence of relevant financial relationships for all individuals in control of content including but not limited to planning committee members, course directors, invited presenters/authors, and staff through a standardized disclosure form.  If a financial relationship is identified for the person in control of content, conflict mitigation strategies will be used to mitigate the financial relationship before they assume their role.

The following financial relationships have been provided:
Fernanda Almeida, DDS, PhD
Advisor: Clinical Advisory Board – Somnomed

Shana Castillo, PharmD, MBA, RPh
No financial relationships to disclose

Atul Malhotra, MD
Consultant: Eli Lilly, Jazz Pharmaceuticals, Livanova, Zoll  

Neomi Shah, MD, MPH, MS
Advisor: Bresotec
Consultant: Respicardia 

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: antiobesity medications for treating OSA

Rush University Medical Center and the Office of Interprofessional Continuing Education staff members, ACHL staff members, and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. Rush University Medical Center and ACHL require the speaker to disclose that a product is not labeled for the use under discussion.

Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting participation will be issued immediately to participants when an individual completes the posttest and evaluation.

Pharmacy credit will be provided to NABP CPE Monitor within 4-6 weeks after the activity completion.

Dentistry certificates will be provided by CME Online within 4-6 weeks after the activity completion.


In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and with commercial support.

Rush University Medical Center designates this Internet Enduring Material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Rush University Medical Center designates this Internet Enduring Material for a maximum of 3.0 nursing contact hour(s ). 

 
Rush University Medical Center designates this application-based Internet Enduring Material for a maximum of 3.0 contact hour(s) for pharmacists. ACPE Universal Activity Number: JA0000275-0000-24-306-H01-P

This activity has been planned and implemented in accordance with the standards of the Academy of General Dentistry Program Approval for Continuing Education (PACE) through the joint program provider approval of CME Online and Academy for Continued Healthcare Learning. CME Online is approved for awarding FAGD/MAGD credit.

Laurie Novoryta
lnovoryta@achlcme.org
Related Activities
View All Activities

You are being redirected to another site.


footer-logo

308 S. Jefferson St.,
Suite 312,
Chicago, IL 60661

  • Phone: 773.714.0705
  • Fax: 773.714.0707
  • Home
  • Specialty
  • Sitemap
  • Privacy Policy
  • Contact Us
  • Follow us on Twitter
  • Like us on Facebook
  • Follow us on LinkedIn

Copyright © 2025 Academy for Continued Healthcare Learning. All Rights Reserved.

Processing...
×